Table 3 Clinical characteristics of patients by group: Mean ± SD or number of patients and (%)
Clinical characteristics | All patients n = 219 | CPG (+) n = 118 | CPG (-) n = 101 | p | |
|---|---|---|---|---|---|
Age (years) | 60.4 ± 15.0 | 60.1 ± 15.3 | 60.7 ± 14.8 | 0.39 | |
Sex (females) | 121 (55.2%) | 66 (56.0%) | 55 (54.5%) | 0.83 | |
Previous cancer | 32 (14.8%) | 15 (12.8%) | 17 (17.2%) | 0.37 | |
Tumour grade | low (grade I) | 38 (20.3%) | 27 (27.6%) | 11 (12.4%) | 0.01 |
intermediate (grade II) | 38 (20.3%) | 18 (18.3%) | 20 (22.5%) | ||
high (grade III) | 70 (37.5%) | 27 (27.6%) | 43 (48.3%) | ||
not applicable | 41 (21.9%) | 26 (26.5%) | 15 (16.8%) | ||
Tumour site | soft tissues | 137 (62.6%) | 71 (60.2%) | 66 (65.4%) | 0.43 |
viscera | 82 (37.4%) | 47 (39.8%) | 35 (34.6%) | ||
Tumour size in mm | 94.6 ± 80.6 | 96.8 ± 91.4 | 91.9 ± 66.3 | 0.67 | |
Tumour depth | superficial | 38 (18.9%) | 22 (20.6%) | 16 (17%) | 0.52 |
depth | deep | 163 (81.1%) | 85 (79.4%) | 78 (83%) | |
Histology | GIST | 54 (25.6%) | 37 (32.5%) | 17 (17.5%) | 0.03 |
Liposarcoma | 45 (21.3%) | 18 (15.8%) | 27 (27.8%) | ||
Leiomyosarcoma | 25 (11.8%) | 9 (7.9%) | 16 (16.5%) | ||
Sarcoma NOS | 16 (7.6%) | 9 (7.9%) | 7 (7.2%) | ||
Dermatofibrosarcoma | 16 (7.6%) | 11 (9.6%) | 5 (5.2%) | ||
Others | 55 (26.1%) | 30 (26.3%) | 25 (25.8%) | ||
Relapse free survival (years) | 2.40 | 2.46 | 2.16 | 0.04 | |